Meal-anticipatory glucagon-like peptide-1 secretion in rats

Endocrinology

Volumn 151, Issue 2, 2010, Pages 569-575

  Vahl, Torsten P ^a   Drazen, Deborah L ^a   Seeley, Randy J ^a   D'Alessio, David A ^a   Woods, Stephen C ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEEDING; FOOD; FOOD INTAKE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MALE; MEAL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL FEED; ANIMALS; APPETITE; BLOOD GLUCOSE; BODY WEIGHT; BRAIN; EATING; ENERGY INTAKE; GLUCAGON-LIKE PEPTIDE 1; INSULIN; KINETICS; MALE; RATS; RATS, LONG-EVANS; TIME FACTORS;

EID: 74949121349     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-1002     Document Type: Article

References (51)

1. Woods SC 1991 The eating paradox: how we tolerate food. Psychol Rev 98:488-505
2. Drazen DL, Vahl TP, D'Alessio DA, Seeley RJ, Woods SC 2006 Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status. Endocrinology 147: 23-30
3. Woods SC, Vasselli JR, Kaestner E, Szakmary GA, Milburn P, Vitiello MV 1977 Conditioned insulin secretion and meal feeding in rats. J Comp Physiol Psychol 91:128-133
4. Katschinski M 2000 Nutritional implications of cephalic phase gastrointestinal responses. Appetite 34:189-196
5. LeBlanc J 2000 Nutritional implications of cephalic phase thermogenic responses. Appetite 34:214-216
6. Mattes RD 1997 Physiologic responses to sensory stimulation by food: nutritional implications. J Am Diet Assoc 97:406-413
7. Powley TL 1977 The ventromedial hypothalamic syndrome, satiety, and a cephalic phase hypothesis. Psychol Rev 84:89-126
8. Powley TL 2000 Vagal circuitry mediating cephalic-phase responses to food. Appetite 34:184-188
9. Strubbe JH, Woods SC 2004 The timing of meals. Psychol Rev 111: 128-141
10. Teff K 2000 Nutritional implications of the cephalic-phase reflexes: endocrine responses. Appetite 34:206-213
11. Woods SC, Strubbe JH 1994 The psychobiology of meals. Psychon Bull Rev 1:141-155
12. Figlewicz DP, Sipols AJ, Porte Jr D, Woods SC, Liddle RA 1989 IVT CCK inhibits food intake and gastric emptying in the baboon. Am J Physiol 256:R1313-R1317
13. Figlewicz DP, Nadzan AM, Sipols AJ, Green PK, Liddle RA, Porte Jr D 1992 Intraventricular CCK-8 reduces single meal size in the baboon by interaction with type-A CCK receptors. Am J Physiol 263:R863-R867
14. Forsyth PA, Weingarten HP, Collins SM 1985 Role of oropharyngeal stimulation in cholecystokinin-induced satiety in the sham feeding rat. Physiol Behav 35:539-543
15. Katschinski M, Dahmen G, Reinshagen M, Beglinger C, Koop H, Nustede R, Adler G 1992 Cephalic stimulation of gastrointestinal secretory and motor responses in humans. Gastroenterology 103: 383-391
16. Konturek JW, Thor P, Maczka M, Stoll R, Domschke W, Konturek SJ 1994 Role of cholecystokinin in the control of gastric emptying and secretory response to a fatty meal in normal subjects and duodenal ulcer patients. Scand J Endocrinol 29:583-590
17. de Jong A, Strubbe JH, Steffens AB 1977 Hypothalamic influence on insulin and glucagon release in the rat. Am J Physiol 233:E380-E388
18. Fischer U, Hommel H, Gottschling HD, Nowak W 1976 The effect of meal feeding and of sham-feeding on insulin secretion in dogs. Eur J Clin Invest 30:465-471
19. Secchi A, Caldara R, Caumo A, Monti LD, Bonfatti D, Di Carlo V, Pozza G 1995 Cephalic-phase insulin and glucagon release in normal subjects and in patients receiving pancreas transplantation. Metabolism 44:1153-1158
20. Teff KL, Mattes RD, Engelman K 1991 Cephalic phase insulin release in normal weight males: verification and reliability. Am J Physiol 261:E430-E436
21. D'Alessio DA, Vahl TP 2004 Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes. Am J Physiol Endocrinol Metab 286:E882-E890
22. Tang-Christensen M, Larsen PJ, Goke R, Fink-Jensen A, Jessop DS, Møller M, Sheikh SP 1996 Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol 271: R848-R856
23. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR 1996 Arole for glucagon-like peptide-1 in the central regulation of feeding. Nature 379:69-72
24. van Dijk G, Thiele TE, Seeley RJ, Woods SC, Bernstein IL 1997 Glucagon-like peptide-1 and satiety? Nature 385:214
25. Delgado-Aros S, Kim DY, Burton DD, Thomforde GM, Stephens D, Brinkmann BH, Vella A, Camilleri M 2002 Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans. Am J Physiol 282:G424-G431
26. Schirra J, Wank U, Arnold R, Göke B, Katschinski M 2002 Effects of glucagon-like peptide-1(7-36)amide on motility and sensation of the proximal stomach in humans. Gut 50:341-348
27. Amori RE, Lau J, Pittas AG 2007 Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA 298:194-206
28. D'Alessio DA, Vahl TP 2005 Utilizing the GLP-1 signaling system to treat diabetes: sorting through the pharmacologic approaches. Curr Diab Rep 5:346-352
29. Seeley RJ, Blake K, Rushing PA, Benoit SC, Eng J, Woods SC, D'Alessio D 2000 The role of CNS GLP-1-(7-36) amide receptors in mediating the visceral illness effects of lithium chloride. J Neurosci 20:1616-1621
30. Elder DA, Prigeon RL, Wadwa RP, Dolan LM, D'Alessio DA 2006 β-Cell function, insulin sensitivity, and glucose tolerance in obese diabetic and nondiabetic adolescents and young adults. J Clin Endocrinol Metab 91:185-191
31. Orskov C, Rabenhøj L, Wettergren A, Kofod H, Holst JJ 1994 Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 43:535-539
32. Vahl TP, Paty BW, Fuller BD, Prigeon RL, D'Alessio DA 2003 Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1-(9-36)NH2 on intravenous glucose tolerance and glucose-induced in-sulin secretion in healthy humans. J Clin Endocrinol Metab 88: 1772-1779
33. Yoshihara T, Honma S, Honma K 1996 Effects of restricted daily feeding on neuropeptide Y release in the rat paraventricular nucleus. Am J Physiol 270:E589-E595
34. Yoshihara T, Honma S, Honma K 1996 Prefeeding release of paraventricular neuropeptide Y is mediated by ascending noradrenergic neurons in rats. Am J Physiol 270:E596-E600
35. Edwards CM, Todd JF, Mahmoudi M, Wang Z, Wang RM, Ghatei MA, Bloom SR 1999 Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes 48:86-93
36. Edwards CM, Stanley SA, Davis R, Brynes AE, Frost GS, Seal LJ, Ghatei MA, Bloom SR 2001 Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers. Am J Physiol Endocrinol Metab 281:E155-E161
37. Gedulin BR, Smith PA, Jodka CM, Chen K, Bhavsar S, Nielsen LL, Parkes DG, Young AA 2008 Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration. Int J Pharm 356:231-238
38. Williams DL, Baskin DG, Schwartz MW 2009 Evidence that intestinal GLP-1 plays a physiological role in satiety. Endocrinology 150: 1680-1687
39. Drucker DJ 2006 The biology of incretin hormones. Cell Metab 3:153-165
40. Brubaker PL 1991 Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides. Endocrinology 128:3175-3182
41. Brubaker PL, Drucker DJ 2002 Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors. Receptors Channels 8:179-188
42. D'Alessio DA, Vogel R, Prigeon R, Laschansky E, Koerker D, Eng J, Ensinck JW 1996 Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons. J Clin Invest 97:133-138
43. Salehi M, Vahl TP, D'Alessio DA 2008 Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion. J Clin Endocrinol Metab 93:4909-4916
44. D'Alessio DA, Kieffer TJ, Taborsky Jr GJ, Havel PJ 2001 Activation of the parasympathetic nervous system is necessary for normal mealinduced insulin secretion in rhesus macaques. J Clin Endocrinal Metab 86:1253-1259
45. Vahl TP, Tauchi M, Durler TS, Elfers EE, Fernandes TM, Bitner RD, Ellis KS, Woods SC, Seeley RJ, Herman JP, D'Alessio DA 2007 Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 148:4965-4973
46. Berthoud HR, Bereiter DA, Trimble ER, Siegel EG, Jeanrenaud B 1981 Cephalic phase, reflex insulin secretion. Diabetologia 20(Suppl): 393-401
47. Louis-Sylvestre J 1978 Feeding and metabolic patterns in rats with truncular vagotomy or with transplanted β-cells. Am J Physiol 235: E119-E125
48. Trimble ER, Berthoud HR, Siegel EG, Jeanrenaud B, Renold AE 1981 Importance of cholinergic innervation of the pancreas for glucose tolerance in the rat. Am J Physiol 241:E337-E341
49. Inoue S, Bray GA, Mullen YS 1978 Transplantation of pancreatic B-cells prevents development of hypothalamic obesity in rats. Am J Physiol 235:E266-E271
50. Brubaker PL, Anini Y 2003 Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2. Can J Physiol Pharmacol 81:1005-1012
51. Dubé PE, Brubaker PL 2004 Nutrient, neural and endocrine control of glucagon-like peptide secretion. Horm Metab Res 36:755-760